These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18598348)

  • 1. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?
    Kerkis I; Ambrosio CE; Kerkis A; Martins DS; Zucconi E; Fonseca SA; Cabral RM; Maranduba CM; Gaiad TP; Morini AC; Vieira NM; Brolio MP; Sant'Anna OA; Miglino MA; Zatz M
    J Transl Med; 2008 Jul; 6():35. PubMed ID: 18598348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.
    Lorant J; Larcher T; Jaulin N; Hedan B; Lardenois A; Leroux I; Dubreil L; Ledevin M; Goubin H; Moullec S; Deschamps JY; Thorin C; André C; Adjali O; Rouger K
    Cell Transplant; 2018 Jul; 27(7):1096-1110. PubMed ID: 29871519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.
    Robriquet F; Lardenois A; Babarit C; Larcher T; Dubreil L; Leroux I; Zuber C; Ledevin M; Deschamps JY; Fromes Y; Cherel Y; Guevel L; Rouger K
    PLoS One; 2015; 10(5):e0123336. PubMed ID: 25955839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.
    Pelatti MV; Gomes JP; Vieira NM; Cangussu E; Landini V; Andrade T; Sartori M; Petrus L; Zatz M
    Stem Cell Rev Rep; 2016 Aug; 12(4):448-53. PubMed ID: 27193781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.
    Sitzia C; Farini A; Jardim L; Razini P; Belicchi M; Cassinelli L; Villa C; Erratico S; Parolini D; Bella P; da Silva Bizario JC; Garcia L; Dias-Baruffi M; Meregalli M; Torrente Y
    Mol Ther; 2016 Nov; 24(11):1949-1964. PubMed ID: 27506452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
    Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
    PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs.
    Sánchez L; Beltrán E; de Stefani A; Guo LT; Shea A; Shelton GD; De Risio L; Burmeister LM
    PLoS One; 2018; 13(2):e0193372. PubMed ID: 29474464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
    Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
    PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological comparison of the smooth uterine muscle of healthy golden retriever bitches, carriers of the progressive muscular dystrophy (GRMD) gene, and GRMD-affected bitches.
    Brolio MP; Cima DS; Miglino MA; Ambrósio CE
    Anim Reprod Sci; 2014 Nov; 150(1-2):56-61. PubMed ID: 25200710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
    Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
    Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
    Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M
    J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.
    Lardenois A; Jagot S; Lagarrigue M; Guével B; Ledevin M; Larcher T; Dubreil L; Pineau C; Rouger K; Guével L
    Proteomics; 2016 Jul; 16(14):2028-42. PubMed ID: 27246553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electroretinographic phenotype of dogs with Golden Retriever muscular dystrophy.
    Beltran WA; Chahory S; Gnirs K; Escriou C; Blot S; Clerc B
    Vet Ophthalmol; 2001 Dec; 4(4):277-82. PubMed ID: 11906664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.